Quick facts
- A pulse oximeter is an active diagnostic device: it supplies energy to monitor a physiological process, which puts it in Class II under Rule 10(1) of Schedule 1 to the Medical Devices Regulations.
- Rule 10(2) moves it to Class III where the device is intended to monitor, assess or diagnose a condition and "erroneous readings could result in immediate danger" — the class follows the intended use, not the hardware.
- The current device standard is ISO 80601-2-61:2026, the third edition, published in April 2026; it cancels and replaces the 2017 edition, which is withdrawn.
- Health Canada's own consumer guidance warns that readings "can be less accurate in people with dark skin", with a normal-looking 94% displayed while true saturation was 88% — a limitation an inspection can ask a clinic to acknowledge.
- Bluetooth adds a second object to the audit: the reading leaves the device and lands in an application, and the classification rules treat dedicated software as part of the device.
- In the United States the same device is Class II under 21 CFR 870.2700 with performance standards, and the FDA has published updated performance-testing and labelling recommendations.
A fingertip oximeter is the smallest device in the room and one of the few that a clinic hands to a patient without a laboratory result to confirm it. When the device is Bluetooth-enabled, the number does not stay in the room: it moves to a phone, into a trend chart, and sometimes into a message thread. That movement is what makes the audit interesting, because the question stops being "does the device work" and becomes "where is the reading, who can see it, and what would you produce if asked". The device discussed here is the Bluetooth pulse oximeter with app trend tracking; the audit questions below apply to any app-connected oximeter a clinic puts into service.
What is an inspector actually auditing when the oximeter is Bluetooth?
Three objects, and the third is the one clinics forget.
The first is the device: a licensed pulse oximeter, used within the intended use the licence declares, in the setting the clinic actually uses it in. The second is the operator: who was trained, on which device, and whether that training predates the first patient reading. The third is the record — and a Bluetooth device changes the shape of the record because the value that a clinician acted on may exist only in an application.
The classification rules anticipate this. Rule 10 of Schedule 1 to the Medical Devices Regulations applies to "an active diagnostic device, including any dedicated software, that supplies energy for the purpose of imaging or monitoring physiological processes". The software is not an accessory bolted onto the regulated object; it sits inside the same rule. A clinic that can produce the licence for the oximeter but not the intended use of the app has answered half the question.
Which licence class applies, and how does that differ between Canada and the United States?
The Canadian answer is a two-step test, and the second step is where the class moves.
Under Rule 10(1), an active diagnostic device that supplies energy to monitor a physiological process is Class II. Under Rule 10(2), a device described in 10(1) that is intended to monitor, assess or diagnose a disease, disorder, abnormal physical state or pregnancy, if erroneous readings could result in immediate danger, is Class III. An oximeter used for spot checks on a stable patient and an oximeter used to monitor a patient during a sedation procedure can therefore be the same box of electronics with a different licence class, because the intended use declares which risk applies.
The American answer is flatter: 21 CFR 870.2700 identifies an oximeter as a device that transmits radiation at known wavelengths through blood and measures oxygen saturation from the reflected or scattered radiation, and classifies it as Class II with performance standards. The regulatory weight then comes through premarket submission and through the labelling and performance expectations that sit around the device.
| Item | Canada | United States |
|---|---|---|
| Governing instrument | Medical Devices Regulations, SOR/98-282 | 21 CFR Part 870 |
| Base class | Class II under Rule 10(1) for monitoring physiological processes | Class II, performance standards, 21 CFR 870.2700 |
| When the class increases | Class III under Rule 10(2) where erroneous readings could result in immediate danger | No classification change; risk is handled through submission and labelling |
| Role of the app | "Dedicated software" is named inside Rule 10, so it is part of the device | Software function is assessed as part of the device submission |
| Safety standard | ISO 80601-2-61:2026 (third edition) plus IEC 60601-1 | Same international standards are used in submissions |
| Where a clinic verifies the claim | Health Canada's MDALL licence record | FDA device classification and 510(k) records |
The difference that matters operationally is that a Canadian clinic can be asked which class the device is licensed in for this use, while an American clinic is more likely to be asked which performance standard and labelling the device was cleared against. Both questions are answerable from documents a clinic should already hold.
What changed in the current pulse oximeter standard?
Standards move, and a device in service for five years may have been declared against an edition that no longer exists. ISO 80601-2-61:2026 was published in April 2026 as the third edition; the standard's own scope note states that it cancels and replaces the second edition, ISO 80601-2-61:2017, which has been technically revised. The 2017 edition is recorded as withdrawn and replaced.
This is not a paperwork detail for manufacturers only. When a clinic writes a device file, the standard edition is part of the evidence: which edition the device was declared against, whether the manufacturer has published a statement about the transition, and whether the instructions for use have changed with it. An inspection that asks "which standard is this device to" is easier to answer than one that asks "why is your file citing a withdrawn edition".
The same logic applies to the general safety standard behind it. IEC 60601-1 is the baseline for medical electrical equipment, and ISO 14971 is the risk-management framework that a manufacturer uses to justify the residual risk the device carries. A clinic does not apply either standard itself; it keeps the manufacturer's declaration, and the declaration names editions.
How is oximeter accuracy framed in Canada compared with the United States?
Canada frames it as a limitation to be communicated. Health Canada's guidance for consumers states that pulse oximeter readings "can be less accurate in people with dark skin", and gives the concrete failure mode: the reading "may display as normal (for example, 94%) when the individual actually has low blood oxygen saturation (for example, 88%)". The same page tells users to check that the device is licensed in Canada through the Medical Devices Active Licence Listing, and advises against relying on the reading alone.
The United States frames it as a performance-testing and labelling question. The FDA published updated recommendations in 2025 covering non-clinical and clinical performance testing, labelling and premarket submission for pulse oximeters, and separately announced a proposal aimed at improving performance across skin tones. For an American clinic the practical consequence is that the instructions for use and the labelling carry the limitations the FDA expected to see, and the device file is judged against those labels.
For a Canadian clinic the two framings combine into one question an inspector can ask: does the person taking the reading know the limitation, and is that written into the procedure? A clinic that trained staff on dark-skin accuracy and on when to escalate rather than act on a single number as the answer has a defensible answer. A clinic that can only say "the device is licensed" has not addressed it.
Which records should exist when the reading goes to a phone?
The record set is small but specific, and it is the part that Bluetooth changes.
| Record | What it should contain | What it proves |
|---|---|---|
| Device file | Licence number and intended use, standard edition declared, date placed in service | The device is licensed for the use the clinic makes of it |
| Operator list | Names, training date, device covered, re-authorisation date | The reading was taken by someone trained on this device |
| Reading record | Patient identifier, date and time, SpO2 and pulse rate, device identifier | The value a decision was made on can be reconstructed |
| App and data note | Which application receives the data, where it is stored, who can export it, retention period | The trend chart is not the only copy of the reading |
| Function check | Battery state, sensor and cable condition, cleaning between patients, any fault and its disposition | The device was in working order at the point of use |
The weak point is the fourth row. A trend stored in a personal phone belongs to whoever holds the phone, and a clinic that has built a monitoring routine on an app should be able to state where the data lives, whether it can be exported in a form that survives a staff departure, and whether patient identifiers enter the app at all. Those are privacy questions as much as device questions, and they are answerable only if someone decided them before the device went into service.
What fails most often with a clinic oximeter?
Four findings recur, and the first two have nothing to do with the sensor.
The first is an oximeter bought for home use and absorbed into clinic use without anyone checking the intended use on the licence. The second is a device that has never been added to the equipment inventory, so no one can say when it was placed in service, when the battery was last replaced, or which staff were trained on it. The third is a reading recorded in an app with no patient identifier, which makes the trend unusable as clinical evidence even though it is complete as data. The fourth is cleaning: a fingertip device passes between patients all day, and the manufacturer's instructions for use define what may be applied to the housing and the sensor window.
None of these is expensive to fix. All of them are difficult to reconstruct after the fact, which is why they show up in inspections rather than in equipment reviews.
What should a clinic check before buying a Bluetooth oximeter?
Five questions, in this order. What is the licence number and the exact intended use — spot check, continuous monitoring, or both? Which standard edition does the manufacturer declare? What does the instructions for use say about skin pigmentation, poor perfusion, nail polish, and movement, and is that limitation reflected in the clinic's procedure? Where does the app store the reading, and can the clinic export it? And what is the cleaning method for the housing and the sensor window?
A clinic that answers those five before purchase will find that the audit questions later are mostly re-reading its own documents. For clinics that also run other near-patient devices, the laboratory consumables range covers the disposable side of the same programme, and the fingertip pulse oximeter, basic SpO2 monitor is the non-connected counterpart for clinics that want a reading without an application attached to it.
Sources
- Medical Devices Regulations, SOR/98-282 — consolidated text (Schedule 1, Part 1, Rules 9 to 12) — read 2026-11-08; page date modified 2026-11-02
- Health Canada — Pulse oximeters: for consumers
- Health Canada — Medical Devices Active Licence Listing (MDALL)
- ISO 80601-2-61:2026 — Particular requirements for basic safety and essential performance of pulse oximeter equipment
- SIS — ISO 80601-2-61:2017, status withdrawn, replaced by the 2026 edition
- 21 CFR 870.2700 — Oximeter
- FDA — Pulse oximeters for medical purposes: non-clinical and clinical performance testing, labeling and premarket submission recommendations
- FDA — Updated recommendations to help improve performance of pulse oximeters across skin tones
- FDA — Device classification database
- ISO 14971:2019 — Application of risk management to medical devices
- ISO 13485:2016 — Medical devices: quality management systems
- ISO 15189:2022 — Medical laboratories: requirements for quality and competence
- CDC — Disinfection and sterilization: sterilizing practices
- Public Health Ontario — laboratory test information index
- Medical Devices Regulations — licence application guidance for IVDDs and near-patient devices
- 42 CFR 493.15 — Laboratories performing waived tests (for the US testing context)
The free compliance log pack includes dated record blocks for device files and daily checks, and the log generator on the same page prints a dated sheet for the current month. A clinic that wants its device record set reviewed before an inspection can ask for an institutional account review rather than rebuild the file from memory. Reselling? become a distributor.
Related reading
- Pulse oximeter monitoring: clinical applications across Canadian healthcare
- Fingertip pulse oximeters in Canadian home care: accuracy standards and procurement
- Home diagnostic devices for Canadian patients: blood pressure monitors, pulse oximeters and thermometers
CliniEco Medical supplies pulse oximeters and clinic consumables in Canada under MDEL #35334. This page describes what inspections ask for; the requirements that bind a clinic are those of its regulator and the manufacturer's instructions for use. Institutional account enquiries go through the account enquiry page.
Frequently Asked Questions
Is a pulse oximeter a Class II device in Canada?
An active diagnostic device that supplies energy to monitor a physiological process is Class II under Rule 10(1) of Schedule 1. Rule 10(2) raises it to Class III where the device is intended to monitor, assess or diagnose a condition and erroneous readings could result in immediate danger, so the intended use decides which class applies.
Does the app count as part of the device?
Rule 10 refers to "an active diagnostic device, including any dedicated software". Software dedicated to the device sits inside the classification rule rather than outside it, which is why the intended use of the application belongs in the device file alongside the intended use of the oximeter.
Which standard edition should a clinic expect to see?
ISO 80601-2-61:2026 is the third edition, published in April 2026, and it cancels and replaces the 2017 edition, which is withdrawn. A device file that names the 2017 edition is not automatically deficient, but the clinic should be able to say which edition the declaration of conformity names.
Why does Health Canada warn about dark skin?
Health Canada's consumer guidance states that readings can be less accurate in people with dark skin, giving the example of a displayed 94% where true saturation was 88%. The clinical consequence is that the reading should be interpreted with other signs rather than used alone, and that limitation belongs in the procedure staff are trained on.
Do Bluetooth readings need to be recorded in the chart?
If a clinician acted on the reading, the clinic should be able to reconstruct what was seen and when. A trend in an application without a patient identifier does not do that, so the practical answer is a chart entry with the value, the time and the device, and an app export that survives staff turnover.
What is the difference between the Canadian and US device routes?
Canada classifies the device under the Medical Devices Regulations and requires a licence for the applicable class, verified through MDALL. The United States classifies an oximeter as Class II under 21 CFR 870.2700 with performance standards and relies on premarket submission plus labelling. Both use the same ISO 80601-2-61 safety standard.